Boehringer Ingelheim has partnered with the UK Cystic Fibrosis Gene Therapy Consortium (GTC), Imperial Innovations, and Oxford BioMedica (OXB) announce a global colla...

Immune Biosolutions has announced a research collaboration and license agreement with Janssen that will focus on the discovery and development of therapeutic antibodi...

The EMA has granted orphan designation to AstraZeneca and MSD's selumetinib, a MEK 1/2 inhibitor, for the treatment of neurofibromatosis type 1 (NF1). NF1 is an incur...

The EMA has granted PRIME designation to Roche's RG6042 for treatment of Huntington’s disease. PRIME (PRIority MEdicines) status is granted to medicines that may offe...

RSP Systems A/S, the non-invasive diagnostics company, announces that it has received the ISO 13485:2016 certificate, demonstrating commitment to placing its non-inva...

Powerful, flexible and easy-to-use analysis solution gets the most out of NGS data Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced the lau...

New options for drug development and treatment of gestational disorders The placenta is the organ connecting mother and embryo. Its main functions are the exchange of...

Sanofi said during a second quarter earnings call on Tuesday morning that it expects to return to growth in the second half of 2018.Yet, the performance for the year ...